All In Biotech

Free tool

FAERS Monitor: Xpovio

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212306 or its brand name (Xpovio, Selinexor). Reports on generic versions are filed under their own applications.

Reports

8,763

Serious

4,819

55% of reports

Hospitalization

2,695

Death reported

1,486

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea2,648
  • fatigue2,018
  • decreased appetite1,406
  • diarrhoea1,351
  • plasma cell myeloma1,199
  • vomiting956
  • asthenia880
  • death866
  • thrombocytopenia768
  • platelet count decreased698
  • weight decreased654
  • off label use545
  • dizziness481
  • pneumonia479
  • anaemia469

Reports by year received

View as table
YearReports
20155
20166
201712
201814
2019606
20201,378
20211,439
20221,235
20231,222
20241,167
20251,051
2026628

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,396 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal1,19976.172.186,181
thrombocytopeniaSignal76816.615.511,219
platelet count decreasedSignal69815.814.79,658
decreased appetiteSignal1,40614.613.917,905
nauseaSignal2,6488.17.816,935
fatigueSignal2,0186.26.09,181
anaemiaSignal4695.95.41,923
weight decreasedSignal6545.65.22,516
astheniaSignal8805.65.33,397
diarrhoeaSignal1,3515.04.84,489
vomitingSignal9564.94.63,014
pneumoniaSignal4793.63.3889
deathSignal8662.42.3746
dizzinessSignal4812.32.1367
off label use5451.51.492

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.